SCHEMBL22989712

SCHEMBL22989712

CC(=O)OCCN(CCOC(C)=O)C1CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.44
DDB1 Q16531 1/20 0.41
CRBN Q96SW2 1/20 0.41
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NAMPT P43490 1/20 0.36
USP30 Q70CQ3 2/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
TACR1 P25103 1/20 0.35
HPGD P15428 1/20 0.35
JAK1 P23458 2/20 0.34
JAK2 O60674 1/20 0.34
RECQL P46063 1/20 0.33
ELANE P08246 1/20 0.33
EPHX1 P07099 1/20 0.33
GPR119 Q8TDV5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22989452 0.82 NR1H2 (0.49) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL17910144 0.81 NR1H2 (0.46) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL18780593 0.80 USP30 (0.47) DDB1CRBNUSP30MEN1ALDH1A1
SCHEMBL29655421 0.79 NR1H2 (0.50) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL24161826 0.79 NR1H2 (0.51) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL30778427 0.74 NR1H2 (0.44) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL12805841 0.74 GPR119 (0.41) HPGDRECQLEPHX1GPR119
SCHEMBL14805523 0.74 NR1H2 (0.47) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL3563885 0.73 DDB1 (0.52) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL21494393 0.72 NR1H2 (0.46) NR1H2DDB1CRBNUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021027943-A1 PYRIMIDINOPYRIDAZINONE DERIVATIVE AND MEDICAL USE THEREOF 正大天晴药业集团南京顺欣制药有限公司 2021-02-18 WO disclosed